Deletions of chromosomes 3p and 14q molecularly subclassify clear cell renal cell carcinoma

被引:39
作者
Kroeger, Nils [1 ,2 ]
Klatte, Tobias [1 ]
Chamie, Karim [1 ]
Rao, P. Nagesh [3 ]
Birkhaeuser, Frederic D. [1 ]
Sonn, Geoffrey A. [1 ]
Riss, Joseph [1 ]
Kabbinavar, Fairooz F. [4 ]
Belldegrun, Arie S. [1 ]
Pantuck, Allan J. [1 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Inst Urol Oncol, Los Angeles, CA 90095 USA
[2] Greifswald Univ Med, Dept Urol, Greifswald, Germany
[3] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA
[4] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA
关键词
renal cell carcinoma; von Hippel-Lindau deletion; hypoxia-inducible factor 1; tumor suppressor gene; cancer-specific survival; recurrence-free survival; POOR SURVIVAL; SURVEILLANCE; MODELS;
D O I
10.1002/cncr.27947
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: The short arm of chromosome 3 (3p) harbors the von Hippel-Lindau (VHL) tumor suppressor gene, and the long arm of chromosome 14 (14q) harbors the hypoxia-inducible factor 1 (HIF-1) gene. The objective of this study was to evaluate the significance of 3p loss (loss VHL gene) and 14q loss (loss HIF-1 gene) in clear cell renal cell carcinoma (ccRCC). METHODS: In total, 288 ccRCC tumors underwent a prospective cytogenetic analysis for alterations in chromosomes 3p and 14q. Tumors were assigned to 1 of 4 possible chromosomal alterations: VHL +3p/+14q (VHL wild type [VHL-WT]), VHL +3p/14q (VHL-WT plus HIF2 [WT/H2]), 3p/+14q (HIF1 and HIF2 [H1H2]), and 3p/14q (HIF2 [H2]). RESULTS: Among patients who had loss of 3p, tumors with 3p/14q (H2) alterations were larger (P = .002), had higher grade (P = .002) and stage (P = .001), and more often were metastatic (P = .029) than tumors that retained 14q (H1H2). All patients who had tumors with 3p/14q (H2) had worse cancer-specific survival (P = .014), and patients who had localized disease (P = .012) and primary T1 (pT1) tumors (P = .008) had worse recurrence-free survival. In patients who had pT1 tumors, combined 3p/14q loss was an independent predictor of recurrence-free survival (hazard ratio, 11.19; 95% confidence interval, 1.91-65.63) and cancer-specific survival (hazard ratio, 15.93; 95% confidence interval, 3.09-82.16). The current investigation was limited by its retrospective design, single-center experience, and a lack of confirmatory protein analyses. CONCLUSIONS: Loss of chromosome 3p (the VHL gene) was associated with improved survival in patients with ccRCC, whereas loss of chromosome 14q (the HIF-1 gene) was associated with worse outcomes. The results of the current study support the hypothesis that HIF-1 functions as an important tumor suppressor gene in ccRCC. Cancer 2013. (c) 2013 American Cancer Society.
引用
收藏
页码:1547 / 1554
页数:8
相关论文
共 28 条
[1]  
[Anonymous], 2009, TNM Classification of Malignant Tumors
[2]   Levels of hypoxia-inducible factor-1α independently predict prognosis in patients with lymph node negative breast carcinoma [J].
Bos, R ;
van der Groep, P ;
Greijer, AE ;
Shvarts, A ;
Meijer, S ;
Pinedo, HM ;
Semenza, GL ;
van Diest, PJ ;
van der Wall, E .
CANCER, 2003, 97 (06) :1573-1581
[3]   PROGNOSTIC-SIGNIFICANCE OF MORPHOLOGIC PARAMETERS IN RENAL-CELL CARCINOMA [J].
FUHRMAN, SA ;
LASKY, LC ;
LIMAS, C .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1982, 6 (07) :655-663
[4]   Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing [J].
Gerlinger, Marco ;
Rowan, Andrew J. ;
Horswell, Stuart ;
Larkin, James ;
Endesfelder, David ;
Gronroos, Eva ;
Martinez, Pierre ;
Matthews, Nicholas ;
Stewart, Aengus ;
Tarpey, Patrick ;
Varela, Ignacio ;
Phillimore, Benjamin ;
Begum, Sharmin ;
McDonald, Neil Q. ;
Butler, Adam ;
Jones, David ;
Raine, Keiran ;
Latimer, Calli ;
Santos, Claudio R. ;
Nohadani, Mahrokh ;
Eklund, Aron C. ;
Spencer-Dene, Bradley ;
Clark, Graham ;
Pickering, Lisa ;
Stamp, Gordon ;
Gore, Martin ;
Szallasi, Zoltan ;
Downward, Julian ;
Futreal, P. Andrew ;
Swanton, Charles .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (10) :883-892
[5]   HIF-α Effects on c-Myc Distinguish Two Subtypes of Sporadic VHL-Deficient Clear Cell Renal Carcinoma [J].
Gordan, John D. ;
Lal, Priti ;
Dondeti, Vijay R. ;
Letrero, Richard ;
Parekh, Krishna N. ;
Oquendo, C. Elisa ;
Greenberg, Roger A. ;
Flaherty, Keith T. ;
Rathmell, W. Kimryn ;
Keith, Brian ;
Simon, M. Celeste ;
Nathanson, Katherine L. .
CANCER CELL, 2008, 14 (06) :435-446
[6]  
Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO
[7]  
2-4
[8]   The Salvador-Warts-Hippo pathway - an emerging tumour-suppressor network [J].
Harvey, Kieran ;
Tapon, Nicolas .
NATURE REVIEWS CANCER, 2007, 7 (03) :182-191
[9]   Predicting cancer-control outcomes in patients with renal cell carcinoma [J].
Isbarn, Hendrik ;
Karakiewicz, Pierre I. .
CURRENT OPINION IN UROLOGY, 2009, 19 (03) :247-257
[10]   Active Surveillance of Small Renal Masses: Progression Patterns of Early Stage Kidney Cancer [J].
Jewett, Michael A. S. ;
Mattar, Kamal ;
Basiuk, Joan ;
Morash, Christopher G. ;
Pautler, Stephen E. ;
Siemens, D. Robert ;
Tanguay, Simon ;
Rendon, Ricardo A. ;
Gleave, Martin E. ;
Drachenberg, Darrel E. ;
Chow, Raymond ;
Chung, Hannah ;
Chin, Joseph L. ;
Fleshner, Neil E. ;
Evans, Andrew J. ;
Gallie, Brenda L. ;
Haider, Masoom A. ;
Kachura, John R. ;
Kurban, Ghada ;
Fernandes, Kimberly ;
Finelli, Antonio .
EUROPEAN UROLOGY, 2011, 60 (01) :39-44